- About us
- Food & AgTech
- Rural Estates
- News & insights
- Contact us
I believe that a continued focus on closing the loop between the genetic merit of an animal or plant and its performance in real life has the potential to drive efficiencies and health outcomes in the years to come. The New B2B will be a detailed understanding of biome to biome interaction between plants, animals and human health outcomes and we are at the dawn of that era.
Prior to joining Grosvenor Food & AgTech (formerly known as Wheatsheaf Group) in 2015, Peter ran Genus PIC in EMEA. Prior to that, Peter worked with the privately held German pharmaceutical company Boehringer Ingelheim, where he held a number of international management positions within Animal Health.
Peter is on the boards of Vytelle Holdings, PrecisionLife and Synomics.
Peter is a Doctor of Veterinary Medicine (DVM) from Copenhagen University, qualified in Agriculture and holds an Executive MBA from IMD, Lausanne.